Henske, Elizabeth P.
Jóźwiak, Sergiusz
Kingswood, J. Christopher
Sampson, Julian R.
Thiele, Elizabeth A.
Article History
First Online: 26 May 2016
Competing interests
: S.J. has been a consultant for UCB Pharma and Eisai, has received speakers honoraria from Novartis and is a site principal investigator for Novartis clinical trials. J.R.S. has received grant funding and honoraria from Novartis. J.C.K. has received honoraria for lectures and consultancy from Novartis. E.A.T. is a consultant for GW Pharmaceuticals and Zogenix, has received grants from GW Pharmaceuticals, Lundbeck and Cyberonics, is a site principal investigator for GW Pharmaceuticals and Zogenix clinical trials and has been a site principal investigator for Novartis clinical trials. E.P.H. has been a consultant to LAM Therapeutics and was an investigator on a Novartis-sponsored trial of everolimus in lymphangioleiomyomatosis, for which no compensation or salary support was provided.